ArticleBMC medical research methodology2026
How reliable are ROC cut-offs? Evidence from simulation and empirical analysis.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReceiver Operating Characteristic (ROC) analysis is commonly used to evaluate how well biomarkers distinguish between diseased and non-diseased individuals. A very important step in this process is choosing an appropriate cut-off value. Although many ROC-based cut-off methods exist, they often lead to different decisions, and guidance on which methods work reliably in practice is limited.
objectiveTo compare commonly used ROC-based cut-off selection methods and identify those that provide stable and balanced diagnostic performance under realistic data conditions.
methodsWe conducted extensive simulation studies using symmetric, skewed, and mixed continuous predictors, varying effect size, variance, and sample size. Multiple ROC-based cut-off methods were evaluated using sensitivity and specificity as the primary performance measures. Findings were further validated using real-world datasets involving blood-based biomarkers.
resultsThe sensitivity and specificity curves showed that across all simulations and real-world datasets, Youden’s index, accuracy-based methods, Cohen’s kappa, and the product of sensitivity and specificity consistently produced stable and well-balanced sensitivity and specificity. In contrast, methods such as the F1 score, ROC01, odds ratio, and risk ratio often produced highly variable results, favouring one diagnostic measure at the expense of the other.
conclusionYouden’s index and the product of sensitivity and specificity offer the most reliable and practical choices for cut-off selection across a wide range of conditions. While other methods may be useful for specific goals, they should be applied with caution in routine diagnostic and prognostic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.